Medical device company ResMed has sold its North Ryde facility as it prepares to move to new, larger premises at Sydney's Norwest Business Park. [ + ]

A chip that will automatically create hundreds of cloned embryos at a time is being developed by a Californian biotech company, New Scientist has learned.

Innovative precision lenses, designed and built in Australia for focusing beams of high-energy ions, form the core of a new breed of high-energy ion beam microscope recently commissioned in Melbourne.

The Australian newspaper has reported, for the first time, what the premiers' positions on stem cell research are as follows:

By measuring nitrogen and phosphorus levels in a sediment core off western Mexico, an international research team led by Edinburgh University's Dr Raja Ganeshram, concludes that climatic change may be a more complex process than was previously thought.

The Western Australian Farmers Federation (WA Farmers) has released its policy on genetically modified organisms. [ + ]

Macquarie Bank has been appointed as financial adviser to the Victorian government's $157 million synchrotron project. [ + ]

The NSW Centre for Agricultural Genomics will expand, after recieving the first injection of funds from the NSW government's BioFirst Intitiative. [ + ]

Early-stage biotech Pestat is developing biological control products based around controlling fertility of pest animals. [ + ]

Melbourne's ES Cell International will supply embryonic stem cells to the National Institutes of Health (NIH) - the first company outside the United States to enter such an arrangement with the biomedical powerhouse. [ + ]

The Australian Law Reform Commission may recommend the Howard government create an Australian equivalent of the UK Human Genetics Commission. [ + ]

Manufacturing has begun on the final version of MicroMedical Industries' VentrAssist artificial heart device. [ + ]

Six early-stage biotechnology companies will share $649,000 in NSW government grants to assist in taking their biomedical technologies through to commercialisation. [ + ]

Australian Technology Innovations Fund (ATIF), a Brisbane-based private investment company, is seeking to invest $50 million in biotechnology projects and companies. [ + ]

Metabolic Pharmaceuticals has gained ethics approval to begin testing its oral obesity drug in patients. [ + ]